BVF Inc’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,409,993
Closed -$44.7M 55
2024
Q3
$44.7M Buy
1,409,993
+247,687
+21% +$9.39M 1.31% 25
2024
Q2
$40.8M Hold
1,162,306
1.14% 25
2024
Q1
$51M Sell
1,162,306
-566,737
-33% -$24.4M 1.4% 20
2023
Q4
$61.5M Sell
1,729,043
-3,554,446
-67% -$106M 1.54% 17
2023
Q3
$143M Sell
5,283,489
-400,000
-7% -$10.1M 3.84% 4
2023
Q2
$134M Buy
5,683,489
+3,228,400
+131% +$66.4M 3.72% 4
2023
Q1
$33.7M Buy
2,455,089
+250,000
+11% +$4.17M 1.23% 27
2022
Q4
$40.1M Sell
2,205,089
-1,089,770
-33% -$18.3M 1.69% 24
2022
Q3
$49.2M Buy
3,294,859
+500,000
+18% +$6.49M 2.03% 17
2022
Q2
$38.6M Buy
2,794,859
+1,194,300
+75% +$13.3M 1.86% 20
2022
Q1
$17.9M Buy
+1,600,559
New +$23.6M 0.72% 36
2021
Q2
Sell
-2,607,969
Closed -$61.3M 72
2021
Q1
$61.3M Sell
2,607,969
-618,800
-19% -$11.9M 2.3% 14
2020
Q4
$45.2M Hold
3,226,769
1.78% 18
2020
Q3
$40.5M Hold
3,226,769
2.21% 17
2020
Q2
$45.9M Buy
3,226,769
+1,941,940
+151% +$15.3M 2.83% 13
2020
Q1
$5.29M Sell
1,284,829
-151,600
-11% -$1.07M 0.49% 37
2019
Q4
$10.8M Sell
1,436,429
-5,000
-0.3% -$35.7K 0.82% 28
2019
Q3
$13M Sell
1,441,429
-64,000
-4% -$488K 1.36% 25
2019
Q2
$15M Buy
+1,505,429
New +$16.4M 1.64% 21

Other funds holding IDYA

BVF Inc's IDYA Position: Q4 2024 in Review

BVF Inc sold out of IDEAYA Biosciences (IDYA) in Q4 2024, closing a stake of 1,409,993 shares — an estimated $44.7M sold.

BVF Inc first reported a position in IDYA in Q2 2019 and held it in 19 quarters. The position peaked at $143M in Q3 2023. 206 funds tracked by Wall St. Rank hold IDYA as of Q4 2024.

  • BVF Inc reported no remaining IDEAYA Biosciences position as of Q4 2024 after selling out during the quarter.
  • BVF Inc sold 1,409,993 IDEAYA Biosciences shares in Q4 2024, an estimated $44.7M.
  • BVF Inc first reported a position in IDEAYA Biosciences in Q2 2019 and held it in 19 quarters.
  • BVF Inc's IDEAYA Biosciences position peaked at $143M in Q3 2023.
  • 206 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2024.

Based on BVF Inc's 13F filing for Q4 2024, filed 14 Feb 2025.